Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel

Indonesia Berita Berita

Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 ScienceMagazine
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 63%

In a study analyzing the Pfizer-BioNTech COVID19 vaccine’s impact in reducing household transmission of SARSCOV2, vaccination reduced risk of transmission by providing protection against susceptibility to infection, even as this effect waned over time.

National Institutes of Health grant R01AI137093 ; National Institutes of Health grant 1DP2HD091799 ; National Institutes of Health grant R01AI112970 ; National Institutes of Health grant NICHD 1DP2HD091799-01 ; Centers for Disease Control and Prevention agreement 6NU50CK000524-01 ; COVID-19 Paycheck Protection Program and Health Care Enhancement Act funding ; Perishing Square Foundation funding .Conceptualization: S.G., T.P., D.M.W., and V.E.P. Methodology: O.P., J.L.W., F.W.C., D.M.W., and V.E.

E.P.D.M.W. has received consulting fees from Pfizer, Merck, GSK, and Affinivax for topics unrelated to this manuscript and is Principal Investigator on research grants from Pfizer ad Merck on unrelated topics. J.L.W. and F.W.C. have received consulting fees from Revelar Biotherapeutics Inc. F.W.C. has received consulting fees from Whitespace Ltd. V.E.P.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

ScienceMagazine /  🏆 285. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variantsVaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variantsVaccination either before or after SARSCoV2 infection may both confer stronger immune responses than vaccination alone, according to a new SciImmunology analysis of serum from 104 vaccinated people.
Baca lebih lajut »

Remembering seasonal coronavirusesRemembering seasonal coronavirusesRemembering seasonal coronaviruses: Two 2020 studies in Science revealed that individuals exposed and unexposed to SARSCoV2 have cross-reactive serum antibodies against the spike protein of SARS-CoV-2 and seasonal human coronaviruses. ScienceMagArchives
Baca lebih lajut »

Bay Area wastewater data suggests COVID cases rising in 3 spotsBay Area wastewater data suggests COVID cases rising in 3 spotsWastewater analyzed for SARS-CoV-2 in four Bay Area counties by researchers at UC Berkeley's Nelson Lab shows interesting trends.
Baca lebih lajut »

Indirect protection of children from SARS-CoV-2 infection through parental vaccinationIndirect protection of children from SARS-CoV-2 infection through parental vaccinationChildren unvaccinated against SARS-CoV-2 may still benefit through protection from vaccinated contacts. We estimated the protection provided to children through parental vaccination with the BNT162b2 vaccine. We studied households without prior infection, ...
Baca lebih lajut »

The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humansThe SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humansAn antibody therapy for COVID19 both prevents and treats SARSCoV2 infections—including with some variants of concern—in large animals, and shows promising activity and extended half-life in human volunteers. ScienceTM
Baca lebih lajut »

Moderna Booster May Wane After 6 Months, Company SaysModerna Booster May Wane After 6 Months, Company SaysThe Moderna vaccine and booster don't protect against Omicron as well as they do against the original SARS-CoV-2
Baca lebih lajut »



Render Time: 2025-03-28 01:14:54